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Schizophrenia (SZ) is a neurodevelopmental disorder caused 
by the interaction of genetic and environmental risk fac-
tors. One of the strongest genetic risk variants is duplica-
tion (DUP) of chr.16p11.2. SZ is characterized by cortical 
gamma-amino-butyric acid (GABA)ergic interneuron dys-
function and disruption to surrounding extracellular matrix 
structures, perineuronal nets (PNNs). Developmental mat-
uration of GABAergic interneurons, and also the resulting 
closure of the critical period of cortical plasticity, is regu-
lated by brain-derived neurotrophic factor (BDNF), although 
the mechanisms involved are unknown. Here, we show that 
BDNF promotes GABAergic interneuron and PNN mat-
uration through JNK signaling. In mice reproducing the 
16p11.2 DUP, where the JNK upstream activator Taok2 is 
overexpressed, we find that JNK is overactive and there are 
developmental abnormalities in PNNs, which persist into 
adulthood. Prefrontal cortex parvalbumin (PVB) expression 
is reduced, while PNN intensity is increased. Additionally, we 
report a unique role for TAOK2 signaling in the regulation 
of PVB interneurons. Our work implicates TAOK2-JNK 
signaling in cortical interneuron and PNN development, and 
in the responses to BDNF. It also demonstrates that over-
activation of this pathway in conditions associated with SZ 
risk causes long-lasting disruption in cortical interneurons.
Key words:  16p11.2 duplication/schizophrenia/CNV/
critical period/CSPGs/parvalbumin
Introduction 
Schizophrenia (SZ) is a devastating mental illness with pos-
itive (eg, delusions and hallucinations) and negative (eg, 
social withdrawal and anhedonia) symptoms combined 
with cognitive deficits.1 SZ is a neurodevelopmental dis-
order, with risk precipitated by genetic and environmental 
factors interacting to impact brain development.2Genetic 
risk involves multiple common variants of small effect. 
Rarely, single copy-number variants (CNVs) carry pow-
erful genetic risk.3,4 The 16p11.2 duplication (DUP) is of 
special interest, as a high proportion of carriers develop 
SZ,5,6 and the effects are largely specific for SZ.7 16p11.2 
DUPs greatly increase the risk for SZ (OR = 10–30) while 
slightly increasing autism risk.8–10 The corresponding de-
letion clearly increases autism risk (OR  =  5–20)10 and 
may slightly promote the risk of SZ-like symptoms.4,11–13
The 16p11.2 DUP region contains ~30 genes, including 
thousand and one kinase 2 (TAOK2) and mitogen-activated 
protein kinase 3 (MAPK3) (encoding the kinases TAOK2 and 
ERK1), both of which are implicated in neurodevelopmental 
disorders.14–16TAOK2 regulates mitogen-activated protein 
(MAP) kinase pathways, notably, the c-jun N-terminal ki-
nase (JNK) pathway, where JNKs 1–3 are activated by up-
stream kinases mitogen-activated protein kinase kinase 
4 (MKK4) or mitogen-activated protein kinase kinase 7 
(MKK7).17,18 JNKs are strongly implicated in CNS develop-
ment.19–22 Interest in JNK is strengthened by an association 
between variations in the MAP2K7 gene (encoding MKK7) 
and prefrontal cortex (PFC) dysfunction in SZ.23
PFC gamma-amino-butyric acid (GABA)ergic 
parvalbumin (PVB) and somatostatin (SST) interneuron 
abnormalities represent a robust pathology in SZ.24,25 
Associated with these interneurons are perineuronal nets 
(PNNs): complex mesh-like extracellular matrix structures 
enwrapping soma and proximal dendrites of, primarily, 
PVB-containing interneurons.26 These nets are dysregulated 
in SZ and in animal models.27–29 PNNs are involved in syn-
aptic stability30 and plasticity,31–33 and their development is 
proposed to be synaptic activity dependent.34
Brain-derived neurotrophic factor (BDNF) pro-
motes GABAergic maturation in the hippocampus and 
cortex.35–37 This is crucial for optimal development, as 
it leads to closure of the critical period of cortical plas-
ticity,38–40 although the precise mechanisms are undefined. 
BDNF has become increasingly associated with SZ,41 
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with reduced levels of BDNF protein and messenger 
RNA (mRNA) in the patients’ blood.42 Considering the 
evidence for BDNF dysfunction in SZ, and its involve-
ment in GABAergic interneuron development, we tested 
the hypothesis that JNK signaling might mediate these 
neurodevelopmental effects. Moreover, we investigated 
the potential disruption of cortical interneurons and 
PNN development in a 16p11.2 DUP mouse model and 
whether the same pathways might be involved.
Methods
16p11.2 DUP Mice
The 16p11.2 DUP mice, which have been described previ-
ously,43 were obtained from the Jackson Laboratory and 
were maintained congenic on a C57Bl6/J background.
Primary Cortical Neuronal Cultures
Primary cortical neurons were prepared using tissue 
from C57Bl6/J mouse embryos (E17), according to our 
standard procedures.44 For DUP cultures, females car-
rying the DUP were mated with wild-type (WT) males 
to produce WT and DUP embryos. Details of pharma-
cological treatments are in corresponding figure legends.
Western Blot and Immunofluorescence
Protein was extracted from cultured neurons at 
14 days in vitro (DIV) and processed for immunoblot-
ting under a standard protocol.45 See supplementary 
table S1 for antibodies and dilutions in immunoblot-
ting. Example images of  full-length blots are available 
in supplementary figure S1.
For immunofluorescence, cells were fixed at 14 DIV 
with 4% paraformaldehyde for 30 minutes and incubated 
with anti-GAD65/67 and biotinylated lectin Wisteria flo-
ribunda agglutinin (WFA) (to detect PNNs) for 24 hours, 
with incubation in appropriate fluorescent secondaries for 
1 hour; 8 DUP (4 female) and 8 C57BL/6 WT (4 female) 
littermates were transcardially perfused under terminal 
anesthesia with 4% paraformaldehyde, brains removed, 
and immersion fixed for a further 24 hours. After pairing 
by genotype and sex, 50 µm sections were incubated in 
50% ethanol for 30 minutes, then with anti-PVB and 
biotinylated WFA for 48 hours, and then with secondary 
antibody for 24 hours. Full details of antibodies used can 
be found in supplementary table S1.
For cultured neurons, z stacks were obtained with a 
Biorad (MRC 1024) confocal microscope (scanning 8 µm 
planes, 0.5 µm steps), settings kept constant across related 
images. From 32 scans (GAD/WFA) from each treatment 
group (8 pairs/group), summed z stacks were analyzed. 
WFA staining intensity was measured using ImageJ. 
Optical densities were expressed as a percentage of ve-
hicle control, unless otherwise stated. For tissue, 50 µm 
(0.5 µm steps) scans were obtained in pairs; 3 scans per 
region, and summed intensity z-stack projections quan-
tified using ImageJ.
Reverse Transcription-Quantitative PCR (RT-qPCR)
PFC tissue was obtained from paired adult WT and 
16p11.2 DUP  mice (10/genotype), and from  postnatal 
day 14 (P14) WT and 16p11.2 DUP (8/genotype) mice. 
RNA was isolated using Qiagen RNeasy mini kits, and 
cDNA then synthesized (ThermoFisher), including noRT 
conditions. Primers (supplementary table S2) were valid-
ated for product size and specificity via gel electropho-
resis. All amplifications were within 90%–110% efficiency. 
RT-qPCR reactions were performed using Fast SYBR 
Green (Applied Biosystems). Data were analyzed using 
∆∆Ct method: Gapdh or Tbp was used as housekeeping 
genes, based on the best stability across all experimental 
conditions.
Statistical Analysis
A complete table of statistics from all analyses can be 
found in supplementary table S3.
Results
BDNF Enhanced Cortical GABAergic Interneuron 
Maturation in a JNK-Dependent Manner
Primary mouse cortical cultures (14 DIV) were stimu-
lated with BDNF to investigate their regulation of cor-
tical GABAergic interneurons, along with inhibitors 
of the JNK signaling pathway (SP600125 [SP]), and 2 
other well-characterized signaling pathways activated by 
BDNF-TrkB stimulation (ERK; PD98059 [PD], PI3K; 
wortmannin [WM]). We measured the levels of the 
GABA-synthesizing enzymes glutamic acid decarbox-
ylase (GAD) GAD65/67 via Western blot and observed 
a clear enhancing effect of BDNF on GAD67 protein 
levels (figures 1a–d). This effect was replicated across all 
BDNF-TrkB inhibition experiments (figures 1e–l).
The accelerating effects on GAD67 maturation were 
negated when BDNF was administered in combination 
with the JNK inhibitor (SP). However, neither PI3K 
(WM) nor ERK (PD) inhibition attenuated BDNF-
induced GAD67 increase. In fact, when BDNF was ad-
ministered with PI3K (WM) or ERK (PD) inhibitors, 
GAD67 protein elevation remained or became further 
pronounced vs vehicle controls (figures 1g and 1k). JNK 
signaling is itself  important to GAD protein expression; 
SP decreased the levels of GAD65 and GAD67 when ad-
ministered to developing neuronal cultures. 
The immunoblots also showed a higher weight 
(~134kDa) protein band that represents a GAD dimer46 
(figures 1d, 1h, and 1l). SP reduced GAD dimer levels, 
while WM appeared to elicit an increase.
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(0.5 µm steps) scans were obtained in pairs; 3 scans per 
region, and summed intensity z-stack projections quan-
tified using ImageJ.
Reverse Transcription-Quantitative PCR (RT-qPCR)
PFC tissue was obtained from paired adult WT and 
16p11.2 DUP  mice (10/genotype), and from  postnatal 
day 14 (P14) WT and 16p11.2 DUP (8/genotype) mice. 
RNA was isolated using Qiagen RNeasy mini kits, and 
cDNA then synthesized (ThermoFisher), including noRT 
conditions. Primers (supplementary table S2) were valid-
ated for product size and specificity via gel electropho-
resis. All amplifications were within 90%–110% efficiency. 
RT-qPCR reactions were performed using Fast SYBR 
Green (Applied Biosystems). Data were analyzed using 
∆∆Ct method: Gapdh or Tbp was used as housekeeping 
genes, based on the best stability across all experimental 
conditions.
Statistical Analysis
A complete table of statistics from all analyses can be 
found in supplementary table S3.
Results
BDNF Enhanced Cortical GABAergic Interneuron 
Maturation in a JNK-Dependent Manner
Primary mouse cortical cultures (14 DIV) were stimu-
lated with BDNF to investigate their regulation of cor-
tical GABAergic interneurons, along with inhibitors 
of the JNK signaling pathway (SP600125 [SP]), and 2 
other well-characterized signaling pathways activated by 
BDNF-TrkB stimulation (ERK; PD98059 [PD], PI3K; 
wortmannin [WM]). We measured the levels of the 
GABA-synthesizing enzymes glutamic acid decarbox-
ylase (GAD) GAD65/67 via Western blot and observed 
a clear enhancing effect of BDNF on GAD67 protein 
levels (figures 1a–d). This effect was replicated across all 
BDNF-TrkB inhibition experiments (figures 1e–l).
The accelerating effects on GAD67 maturation were 
negated when BDNF was administered in combination 
with the JNK inhibitor (SP). However, neither PI3K 
(WM) nor ERK (PD) inhibition attenuated BDNF-
induced GAD67 increase. In fact, when BDNF was ad-
ministered with PI3K (WM) or ERK (PD) inhibitors, 
GAD67 protein elevation remained or became further 
pronounced vs vehicle controls (figures 1g and 1k). JNK 
signaling is itself  important to GAD protein expression; 
SP decreased the levels of GAD65 and GAD67 when ad-
ministered to developing neuronal cultures. 
The immunoblots also showed a higher weight 
(~134kDa) protein band that represents a GAD dimer46 
(figures 1d, 1h, and 1l). SP reduced GAD dimer levels, 
while WM appeared to elicit an increase.
Fig. 1. Brain-derived neurotrophic factor (BDNF) enhances GAD67 maturation in a JNK signaling-dependent manner. Western blot 
analysis of cortical neuronal cultures treated at 7 days in vitro (DIV) for 7 days with (a–d) vehicle, BDNF (50 ng/ml), JNK inhibitor 
(SP600125; 5 μM), or BDNF + SP600125. (e–h) vehicle, BDNF, PI3K inhibitor (wortmannin; 100 nM), or BDNF + wortmannin. (i–l) 
vehicle, BDNF, ERK inhibitor (PD98059; 40 µM) or BDNF + PD98059. N = 9 in all cases. BDNF increased GAD67 in all cases (c, g, 
k), but GAD65 and GAD dimer were generally unchanged (b, f, j, d, h, l). JNK inhibition negated the enhancing effect of BDNF on 
GAD67 levels (c). PI3K (g) and ERK (k) inhibition did not alter the response to BDNF. Data are presented as boxplots with medians, 
interquartile ranges, and “Tukey” whiskers; crosses indicate sample means. (m, n) immunocytochemical analysis of GAD65/67 and 
Wisteria floribunda agglutinin (WFA) labeling in primary cortical neuronal cultures treated with either vehicle, SP600125, BDNF, or 
BDNF + SP600125. N = 5 cultures (minimum 239 observations per condition). Representative images show WFA and merged stacked 
confocal imaged WFA + GAD65/67. Scale bars = 66 µm. WFA intensity was increased by BDNF treatment, but this effect was negated 
D
ow
nloaded from
 https://academ
ic.oup.com
/schizophreniabulletin/advance-article/doi/10.1093/schbul/sbaa139/5928108 by guest on 23 O
ctober 2020
Page 4 of 15
A. Willis et al
PNNs in vitro do not reach maturation until around 
21 DIV,47 so are still developing at 14 DIV, but with net-
like structures clearly present around the cell soma and 
proximal dendrites (figure 1m). BDNF increased the den-
sity of cell-body enwrapping PNNs (WFA staining inten-
sity) (P < .001), an effect attenuated by JNK inhibition 
(figure  1n). Mirroring our above findings, SP alone re-
duced WFA intensity (P < .001).
While lectin labeling provides an excellent method of 
visualizing PNNs, they are composed of a complex com-
bination of chondroitin sulfate proteoglycans (CSPG), 
link proteins, and other extracellular molecules.48 For a 
more detailed view of regulatory effects on PNN devel-
opment, we treated cortical neurons with vehicle, JNK-
Inhibitor-8 (JNK-IN-8), BDNF, or BDNF + JNK-IN-849 
and analyzed key PNN gene expression (figure 2a, sup-
plementary figure S2). 
Cultures treated with either vehicle or BDNF for 7 
DIV at 14 DIV had higher expression of major PNN 
CSPGs, brevican (Bcan), neurocan (Ncan), and versican 
(Vcan). Importantly, this BDNF-induced upregulation 
in CSPG expression was attenuated by JNK inhibition. 
Additionally, we found BDNF-induced upregulation of 
hyaluronan synthase 3 (Has 3), 1 of the 3 core enzymes 
responsible for the synthesis of the hyaluronan backbone 
of PNNs. Interestingly, this upregulation was not JNK 
dependent.
To further investigate whether BDNF accelerated 
cortical interneuron maturation, we measured the ex-
pression of  a highly developmentally regulated Gad1 
transcript (Emb Gad1), which is expressed embryoni-
cally and declines throughout postnatal development to 
barely detectable expression in adulthood.50–52 We also 
measured Kcnc1, encoding Kv3.1b potassium channels 
that are enriched in fast-spiking PVB interneurons.53,54 
Kcnc1 is also strongly developmentally regulated, with 
maximal expression observed in adulthood.55 Finally, we 
measured Pax6 expression, a gene implicated in a range 
of  cortical developmental processes.56 Pax6 expression is 
highest during embryonic and early postnatal develop-
ment, after which it declines rapidly, becoming confined 
to remaining immature neurons in the dentate gyrus and 
olfactory bulb.57
BDNF treatment reduced the expression of Emb Gad1 
(with a trend toward Pax6 reduction) while increasing 
Kcnc1 expression (figure 2b). This pattern of gene expres-
sion, coupled with increased WFA labeling and CSPG 
expression, is indicative of a more mature GABAergic in-
terneuron phenotype.
Disruption to JNK Signaling Results in PNN 
Component Dysregulation
Expression of the 4 major CSPGs was substantially reduced 
with JNK signaling inhibition (figure 2a and supplementary 
figure S2). A similarly large reduction was found in Sema3a 
mRNA (figure  2a and supplementary figure S2); consid-
ering the binding between specific CSPGs and SEMA3A 
protein,58 it is intriguing that they change in synchrony. 
Conversely, the expression of Has 1–3 showed substantial 
upregulation (figure 2a and supplementary figure S2).
16p11.2 DUP Neurons Develop Abnormally
The 16p11.2 DUP contains 2 critical MAPK pathway 
genes: Taok2, an upstream regulator of JNK, and Mapk3 
(ERK1). While abnormal dendritic phenotypes in cul-
tured neurons carrying the 16p11.2 micro-DUP have 
implicated increased Mapk3 expression as a major influ-
ence,15 Taok2 also functions in dendritic growth, spine/
synapse development, and excitatory neurotransmission.14
MAPK Activity Is Elevated in 16p11.2 DUP Neurons. We 
confirmed elevated JNK activity in DUP neurons, involving 
all 3 pJNK isoforms (figures 3a and 3b). In WT cultures, our 
data showed a clear elevation of pJNK 1–3 (figures 3a and 
3b), and pERK (figures 3e and 3f), in response to BDNF. 
However, BDNF treatment of DUP culture did not elicit an 
increase in pJNK. This trend was the same in pERK levels, 
where DUP basal levels are already elevated vs WTs, and 
DUP pERK was unaffected by BDNF treatment.
GABAergic Markers and PNNs Are Dysregulated in 16p11.2 
DUP Neurons. DUP cultures exhibited dysregulated 
GAD, especially the 65-kDa isoform (figures 3c and 3d). 
Despite BDNF not clearly affecting the levels of the 
basally higher pJNK or pERK in DUP cultures, BDNF 
upregulated GAD67 levels comparably to WT cultures. 
This suggests that other downstream TrkB pathways 
are also involved in the effects of BDNF. Additionally, 
we found increased GAD dimerization in DUP cultures 
(figure  3d), the inverse of observations with JNK inhi-
bition (figure 1d). These data support a role for JNK in 
functional GAD activity and suggest the dysregulation 
of GAD in 16p11.2 DUP neurons.
PSD-95 is an organizer of post-synaptic signaling com-
plexes at glutamatergic synapses, with expression regulated 
according to the levels of synaptic activity.59 It is also regu-
lated by phosphorylation via JNKs, which leads to an ad-
ditional (more slowly migrating) immunoreactive band on 
when JNK was inhibited. Raincloud plots show the probability density of immunocytochemical intensity data (ie, half  violin) and 
notched boxplots, and horizontal lines plot the mean. Data were analyzed via 3-way ANOVA with factors BDNF, inhibitor, and culture. 
Factors BDNF and inhibitor were crossed to investigate any potential interaction. **P < .05, ***P < .01 Tukey post hoc significance vs 
indicated condition. $ indicates  a significant interaction. The main effects are denoted by ## on graph legends. A full summary of F and 
P-values is contained in supplementary table S3 for all effects found  in the analysis. 
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Fig. 2. Brain-derived neurotrophic factor (BDNF) increases chondroitin sulfate proteoglycan (CSPG) (Bcan, Ncan, and Vcan) 
mRNA expression in a JNK-dependent manner and enhances the maturity of cortical neurons in culture. mRNA expression of key 
(a) perineuronal net (PNN) components (CSPGs, hyaluronan synthases [Has1-3], Sema3a) in cortical neuronal cultures treated with 
vehicle, JNK-IN-8 (1 μM), BDNF (50 ng/ml), or JNK-IN-8 + BDNF and (b) markers of cortical neuron maturity (embryonic Gad1, 
Kcnc1, and Pax6) were assessed in cortical neuronal cultures treated with vehicle or BDNF (50 ng/ml). All treatments were administered 
at 14 days in vitro (DIV) for 7 DIV (ie, RNA extracted at 21 DIV). The later time point chosen for inhibition (14–21 DIV) reflected 
the low levels or later developmental onset of some target genes and the subsequent requirement to have culture extracts containing 
high enough expression for qPCR detection. Relative expression was calculated using the ∆∆Ct method with Tbp housekeeping gene. 
Data are presented as boxplots with medians, interquartile ranges, and “Tukey” whiskers; crosses indicate sample means. Data (a) were 
analyzed via 2-way ANOVA (factors: BDNF, inhibitor) with Tukey post hoc multiple comparisons. Factors were crossed to investigate 
any significant BDNF-inhibitor interaction. **P < .05, ***P < .01 Tukey post hoc significance vs indicated condition. Sema3a and Has2 
vehicle vs JNK-IN-8 conditions were further analyzed via Mann-Whitney U-tests. # represents a significantly lower median expression 
of Sema3a, or a higher median expression of Has3, compared with vehicle. (b) Markers of cortical neuron maturity were analyzed via an 
independent sample t-test. ** represents significance vs vehicle (P < .05). n = 6 independent samples per condition. 
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Fig. 3. 16p11.2 Duplication (DUP) neurons exhibit increased JNK activity, dysregulated GAD in vitro, and accelerated interneuron 
and perineuronal net (PNN) maturation in ex vivo postnatal prefrontal cortex (PFC). Primary neuronal cultures were obtained from 
16p11.2 DUP and WT littermate embryos (E17) and were treated at 7 days in vitro (DIV) with either vehicle or BDNF (50 ng/ml) 
for 7 days. (a–g) Representative images and quantitative analysis of pJNK (a, b), GAD65/67 and GAD dimer (c, d), and pERK (e, 
f) in WT vs 16p11.2 DUP via Western blot. N = 18 (pJNK, tJNK, and GAD65/67), N = 9 (GAD dimer), and N = 15 (pERK and 
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Western blots.60,61 Therefore, we investigated the differences 
in PSD-95 phosphorylation/expression between WT and 
DUP cultures and observed 2 PSD-95 bands (figures  3g 
and 3h). To confirm the dependence of the more slowly 
migrating immunoreactive band on JNK activity, in WT 
cultures, as expected, SP produced a marked reduction in 
upper band intensity (figure 3g). BDNF enhanced the in-
tensity of the higher weight, JNK-phosphorylated, form of 
PSD-95 protein in WTs (figures 3h and 3i). Basal levels of 
the upper isoform were markedly elevated in DUP cultures 
(figures 3h and 3i). Moreover, consistent with no increase in 
JNK activity in BDNF-treated DUP cultures, we found no 
further elevation of the high-weight PSD-95 isoform after 
BDNF treatment (figures 3h and 3i).
We observed an increase in DUP WFA staining inten-
sity at 14 DIV (figures 3j and 3k). This may appear coun-
terintuitive, considering the deficit in GABA synthesis. 
However, this finding aligns with the heightened JNK 
activity in these DUP cultures. Mirroring the trends in 
pJNK, BDNF did not increase WFA intensity in DUP 
cultures, but this effect was clear in WT cultures.
Postnatal 16p11.2 DUP Mice Exhibit an Interneuron 
Phenotype Indicative of Accelerated Development. PNNs 
have a well-established role in development and synaptic 
plasticity, with denser or “tighter” nets being suggested 
as “brakes” on the developmentally timed restriction of 
cortical plasticity.31,32,62–64 Since DUP neurons exhibited 
denser PNNs in culture, we wished to explore whether this 
was indicative of an accelerated GABAergic interneuron 
developmental phenotype compared with WT mice.
We assessed the mRNA expression of key PNN CSPGs, 
mature Gad1, Pvalb, Kcnc1, and Emb Gad1 in PFC sam-
ples from P14 WT and 16p11.2 DUP mice via RT-qPCR. 
We found a marked increase in Bcan expression in P14 
DUP PFC compared with WT (figure 3l). Interestingly, 
Bcan expression changes have been linked to the closure 
of the critical period.65 Our analysis also revealed the 
higher expression of mature Gad1, Pvalb, and Kcnc1 in 
DUP mice, while Emb Gad1 was significantly reduced 
compared with WTs (figures  3m and 3n). These results 
indicate a clear acceleration in interneuron development 
and earlier PNN maturation in postnatal DUP mice.
Adult 16p11.2 DUP Mice Have Sustained PNN 
Abnormalities and Interneuron Deficits in PFC and 
Thalamic Reticular Nucleus
We then investigated PNNs in adult mice carrying the 
DUP, focussing on 2 regions particularly pertinent to 
SZ, the PFC and the thalamic reticular nucleus (TRN), 
which are anatomically and functionally closely con-
nected with the PFC, and where dysfunction is linked to 
SZ etiology.66,67 Additionally, given the link between PVB 
deficits and SZ, we monitored PVB levels via immuno-
fluorescence intensity. WFA intensity was significantly 
increased in DUP compared with WT mice, indicating 
denser PNNs in these regions (figures  4a–d). Data for 
PVB are more nuanced. PVB intensity levels in TRN 
tended toward increased levels in DUPs. However, in 
PFC, we observed a clear reduction in PVB levels vs WTs.
Conducting a finer grain analysis of PNN components 
via RT-qPCR (figure 4e), the 2 major PNN components 
with increased expression in DUP vs WT PFC were 
Ncan and Sema3a (figure  4e). Considering the impor-
tance of PNNs in plasticity, we also investigated whether 
these processes may be perturbed in DUP mice, using 
the immediate early gene markers (IEGs) cFos and Arc. 
Expression of cFos was elevated in DUPs, with evidence 
of a genotype-sex interaction (supplementary figure S3).
TAOK and ERK Inhibition Disrupt PNN Regulation 
and Interneuron Maturation in Developing Cortical 
Neurons In Vitro
Our findings linked JNK, and potentially TAOK2, to the 
regulation of  GABAergic interneuron genes expression. 
To test TAOK2 involvement, we employed the selective 
TAOK inhibitor CP-4368,69 in WT cortical neurons. We 
found that TAOK inhibition reduced all pJNK isoforms 
(supplementary figure S4), most prominently for the 
smallest JNK isoform (p46) (reduction of  around 60% vs 
vehicle). We assessed whether elevated Taok2 (TAOK2) 
tERK) independent samples/condition, each of 3 independent cultures. (g) Representative images and Western analysis of specific 
JNK-phosphorylated form of PSD-95. N = 6 independent samples/condition, from each of 2 independent cultures. (h, i) This JNK-
phosphorylated form of PSD-95 was found at increased basal levels in DUP cultures, compared with WTs via Western blot. N = 6 
independent samples/condition, each of 3 independent cultures. (j, k) Immunofluorescent images and optical intensity analysis of 
cultured neurons from WT and DUP cultures treated with either vehicle or BDNF at 7 DIV for 7 days, labeled with WFA lectin and 
GAD65/67. DUP neurons had increased Wisteria floribunda agglutinin (WFA) staining intensity, which, unlike WT cultures, was 
unaffected by BDNF treatment. N = 18 independent samples/condition, each of 3 independent cultures. Minimum 8 confocal scans/
independent sample, with at least 60 WFA measurements per condition. Scale bars = 54 µm. (l, m) mRNA expression of key CSPGs 
(l), Gad1 and Pvalb (m), and markers of cortical neuron maturity, Kcnc1, and Emb Gad1 (n) were measured in samples of postnatal 
day 14 WT and 16p11.2 DUP PFC. N = 8 per genotype. For boxplots: Center lines show the medians, box limits indicate the 25th and 
75th percentiles; whiskers extend 1.5 times the interquartile range from the 25th and 75th percentiles; crosses indicate sample means. 
O represents outliers. RT-qPCR data were analyzed via 1-way ANOVA. ** represents Tukey post hoc significance compared with WT 
vehicle (or as detailed via graph lines) (P < .05) and *** (P < .01). ## indicates the main effect of genotype (as indicated by dashed lines) 
or treatment (as indicated on graph legend).
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Fig. 4. Perineuronal net (PNN) density is increased in adult 16p11.2 duplication (DUP) prefrontal cortex (PFC) and thalamic reticular 
nucleus (TRN), while PFC parvalbumin (PVB) levels are reduced. Labeling intensity of Wisteria floribunda agglutinin (WFA) lectin and 
PVB was measured in PFC and TRN of adult 16p11.2 DUPs and paired WTs. (a, b) provide representative z-stack images of PFC (a) 
and TRN (b). Raincloud plots of labeling intensity of PVB and WFA in the PFC (c) and TRN (d) indicate increased WFA intensity 
in DUP PFC and TRN vs WT. PVB was significantly lower in the PFC of DUP mice vs WTs, but unchanged in the TRN. Data were 
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and Mapk3 (ERK1) in 16p11.2 DUP mice relate to the 
increased PNN density and reduced PVB. In WT cul-
tures treated with either vehicle, ERK inhibitor (PD), 
or TAOK inhibitor (CP-43), Acan expression was re-
duced with TAOK inhibition. Sema3a expression was 
also reduced when either TAOK or ERK was inhibited 
(figure 5a). All other PNN components were unchanged 
with ERK inhibition (figure  5a). However, supporting 
previous findings where JNK was inhibited, we saw 
an increase in Has1 expression with TAOK inhibition 
(figure 5a).
TAOK inhibition increased Pvalb expression 
(figure  5b), the inverse of observations in DUP mice 
which overexpress Taok2. A modest increase in Pvalb ex-
pression was found with ERK inhibition. In both ERK 
and TAOK inhibition conditions, we found reduced Sst 
expression (figure  5b). While cFos expression was un-
changed when either TAOK or ERK was inhibited, there 
is some indication of altered network activity, with Arc 
expression markedly lower in both conditions (figure 5b). 
Furthermore, we found reduced Dlg4 (PSD-95) expres-
sion with both treatments, suggesting the inhibition of 
these pathways causes aberrant synaptic regulation and 
altered plasticity.
Discussion
Our work aimed to understand the mechanisms of BDNF 
regulation of cortical GABAergic interneuron develop-
ment and the extent to which they might be comprom-
ised in a mouse model of the SZ-related 16p11.2 DUP 
syndrome.
BDNF Enhances Cortical GABAergic Maturation in a 
JNK-Dependent Manner
Our data highlighted an enhancing effect of BDNF on 
cortical interneuron maturation which supports previous 
research.35,70 BDNF increased the levels of GAD67, 
WFA labeling intensity, Kcnc1, Ncan, Bcan, and Vcan ex-
pression and reduced embryonic Gad1 transcript levels, a 
pattern strongly suggestive of a more mature GABAergic 
interneuron phenotype. The modulation of key PNN 
CSPGs by BDNF is important regarding evidence that 
BDNF controls the closure of the critical period of 
plasticity in cortical development,38–40 since the matura-
tion of PNNs is suggested directly to curtail this plastic
ity.31,32,48,64,71,72
Various studies have highlighted distinct roles for 
mature and precursor forms of BDNF (mBDNF and 
proBDNF, respectively).73 mBDNF binds TrkB with high 
affinity but neurotrophin receptor p75NTR with low af-
finity.74,75 Conversely, proBDNF primarily binds p75NTR, 
with lower affinity for TrkB.76 We administered only 
mBDNF in this study, so the enhancing effects of BDNF 
on GABAergic and PNN maturation are likely driven by 
mBDNF-TrkB. Given the differing roles of mature and 
precursor BDNF isoforms, it may also be interesting to 
investigate the effects of proBDNF on interneuron mat-
uration, and how alterations to the ratios or mBDNF/
proBDNF may alter the developmental trajectory of 
GABAergic neurons.
We found that the enhancing effect of BDNF depends 
on JNK signaling; the accelerating effects on GAD67 
and WFA intensity were negated with JNK inhibition. 
However, this was not the case when alternative down-
stream TrkB pathways were inhibited (eg, ERK or PI3K). 
Moreover, the BDNF upregulation of Bcan, Ncan, and 
Vcan was attenuated when JNK was inhibited. These 
data implicate the JNK pathway in BDNF-TrkB effects 
on developing GABAergic interneurons.
JNK Signaling Is Critical for GABAergic and PNN 
Development
JNK inhibition disrupted PNN development and de-
creased the density of PNNs at 14 DIV as assessed by 
WFA labeling. CSPG expression (Acan, Vcan, Ncan, 
and Bcan) were all disrupted after JNK inhibition, and 
Sema3a expression was also reduced. SEMA3A, which 
binds to CSPGs of PNNs, has a role in axonal outgrowth 
and neuronal migration and may contribute to PNNs 
modulation of structural neural plasticity.58,77
Conversely, JNK inhibition increased the expression 
of Has1-3. HAS 1-3 are membrane-bound enzymes that 
synthesize hyaluronan (the backbone upon which CSPGs 
bind to compose PNNs). HAS1-3 appear to have a dy-
namic role throughout development, where PNNs un-
dergo extensive maturation and modeling.78 Since HAS 
activity is essential for the formation of the core back-
bone of new PNNs, we speculate that the upregulation of 
Has1-3 in response to JNK inhibition is a compensatory 
feedback response to the downregulation of CSPGs.
JNK pathway inhibition also reduced GAD65 and 
GAD dimerization. An SZ-causing Gad67 mutation 
analyzed via 3-way ANOVA with factors genotype, sex, and pair, with factors genotype and sex crossed to investigate any interaction. 
N = 8 per genotype (4 male and 4 female). Minimum three 50-µm (20× obj. 0.5-µm steps) confocal scans analyzed per region, per mouse. 
Quantification was performed on summed intensity z-stack projections. Scale bars = 500 µm (PFC, tiled image), 20 µm (PFC, 40×), 
200 µm (TRN, tiled image), and 50 µm (TRN, 20×). For raincloud plots: o is individual measurements, half  violins represent probability 
density of data (ie, kernel density estimation), boxplots are notched on the median, and horizontal lines represent the mean. ***P < .01 
represent Tukey post hoc significance vs WT. (e) Expression of key PNN components was measured in samples of adult WT and 16p11.2 
DUP PFC. Relative expression was calculated using the ∆∆Ct method with Gapdh housekeeping gene. Data are presented as boxplots 
with medians, interquartile ranges, and “Tukey” whiskers; crosses indicate sample means. N = 10 per genotype (5 male and 5 female). 
RT-qPCR data were analyzed via 1-way ANOVA. **P < .05 and ***P < .01 represent Tukey post hoc significance vs WT.
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Fig. 5. Pharmacological inhibition of TAOK and ERK disrupts the expression of key perineuronal net (PNN) and GABAergic genes 
and model of abnormal development in 16p11.2 duplication (DUP) neurons. Expression of key (a) PNN genes, (b) Pvalb, Sst, and Dlg4 
(PSD-95), and immediate early genes (IEGs: cFos and Arc) in WT cultures treated at 16 days in vitro (DIV) for 5 days with either vehicle, 
CP-43 (TAOK inhibitor; 30 μM), or PD (ERK inhibitor; 40 μM) was measured via RT-qPCR. Relative expression was calculated using 
the ∆∆Ct method with Tbp housekeeping gene. Data are presented as boxplots with medians, interquartile ranges, and “Tukey” whiskers; 
crosses indicate sample means. N = 8 independent samples per condition. Data were analyzed via 1-way ANOVA. Additionally, a Mann-
Whitney U-test was performed for vehicle vs CP-43-treated samples on Acan and Has1 data, where we found the median expression 
of Acan and Has1 to be significantly lower or higher, respectively, in CP-43 samples (P = .05 and P = .02, respectively). **P < .05; 
***P < .01 (Tukey post hoc significance). (c) 16p11.2 DUP neurons exhibit an abnormal developmental phenotype that may involve 
a premature closure of the critical period, as supported by elevated Wisteria floribunda agglutinin (WFA), Ncan, Kcnc1, mature Gad1, 
and Pvalb expression, and downregulated embryonic Gad1. Considering the data presented here, this is likely to be driven by Taok2 
over-expression and subsequent over-activity of JNK. Given the importance of parvalbumin (PVB)+ interneurons in the regulation of 
excitatory/inhibitory balance within cortical regions, accelerated GABAergic development may lead to dysregulated network activity and 
synaptic connectivity, potentially evidenced by an elevation in cFos in adult DUP prefrontal cortex (PFC). Pvalb expression is reduced 
in adult DUP PFC, which may indicate a compensatory mechanism to achieve network balance. Heightened PNN density is sustained 
into adulthood in DUP mice. Elevated JNK activity in developing DUP neurons may underlie sustained increased PNN density. 
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impairs GAD dimerization.79 Since JNK dysfunction has 
been implicated genetically and phenotypically with SZ 
in human cohorts and rodent models,23,80,81 the JNK regu-
lation of GAD dimerization may be clinically important.
16p11.2 DUP Neurons Exhibit an Abnormal 
Developmental Trajectory
Basally, the levels of pJNK and pERK were heightened 
in DUP neurons. GAD levels were lower in DUP cultures 
vs WTs, while GAD dimerization was elevated. This sug-
gests an overall functional dysregulation of GAD which, 
given the aforementioned data implicating JNK-signaling 
in GAD dimerization, may relate to heightened TAOK-
JNK activity. BDNF appears to remedy these GAD65/67 
deficits, increasing levels to match those in untreated WT 
cultures. However, GAD dimer levels are not reduced. In 
DUP neurons, this mechanism does not recruit JNK or 
ERK, suggesting a reliance on alternative pathways. This 
may result from elevated basal levels of JNK and ERK, 
meaning the BDNF response is sequestered to another 
TrkB pathway.
Additionally, carriers of the 16p11.2 DUP and deletion 
may have disruption to the PI3K/Akt, as well as MAPK 
pathways as shown here, due to DUP of the major vault 
protein (Mvp) gene included in the region. MVP regulates 
the intracellular localization of the protein PTEN, which 
can antagonize PI3K/Akt.82,83 This disruption, coupled 
with the lack of JNK and ERK response to BDNF shown 
here, suggests a broadly altered intracellular response to 
BDNF with the 16p11.2 DUP—potentially a key compo-
nent of the neurodevelopmental pathology observed in 
16p11.2 CNV syndromes. Indeed, BDNF is not only a 
critical growth factor during development. Since it is also 
implicated in synaptic plasticity in maturity, altered intra-
cellular responses to BDNF will produce lasting deficits 
that could contribute to the maintenance of interneuron 
pathology and symptomology observed in the SZ-related 
16p11.2 DUP syndrome.
WFA labeling intensity was notably higher in DUP 
vs WT-cultured neurons, indicating DUP PNNs reach a 
more mature density earlier. In P14 PFC of DUP mice, we 
found heightened expression of Bcan, Kcnc1, Pvalb, and 
mature Gad1 and lowered expression of a developmen-
tally regulated Gad1 transcript (Emb Gad1) compared 
with WTs. This further suggests abnormal interneuron 
development in DUP mice and is a clear indication of 
precocious GABAergic interneuron development.
This may appear inconsistent with the observed GAD 
reduction in DUPs, but, considering the pJNK increase 
in DUP neuronal cultures, it is concurrent with the idea 
that JNK signaling is crucially important for GABAergic 
development; in this instance, the development of PNNs. 
Moreover, in relation to the SZ-related 16p11.2 DUP, this 
may indicate an abnormally early closure of the critical 
period of plasticity. The premature closure of this highly 
plastic window could have profound consequences on the 
network activity and synaptic connectivity in adulthood.
16p11.2 DUP Mice Display GABAergic Interneuron 
and PNN Abnormalities Into Adulthood
Analysis of  adult DUP vs WT PFC revealed that ac-
celerated interneuron development in DUPs, and subse-
quent upregulation of  Pvalb and Gad1, does not result 
in a sustained elevation of  PVB protein expression in 
adulthood. Instead, we found that adult DUPs exhib-
ited reduced PVB protein levels in the PFC. This is in 
line with our previous findings of  a decrease in Pvalb 
mRNA expression in the PFC and hippocampus of 
adult DUP mice.84
We speculate that this early closure of the critical 
period and accelerated development may lead to altered 
network activity and dynamics, which are sustained into 
adulthood, and may be mediated by Pvalb levels. Our 
cFos data highlight the increased network activity in 
DUPs adults, which further suggests a pathological dis-
inhibition in these mice. PVB + GABAergic interneurons 
are known to be the major control mechanism for setting 
excitation/inhibition balance in the PFC.85–87 We theorize 
that Pvalb expression may be downregulated as a com-
pensatory mechanism, in an attempt to restore normal 
excitation/inhibition balance. A schematic outline of the 
altered developmental pattern of DUP neurons, along 
with our suggested mechanisms, is in figures 5c and 5d.
Interestingly, heightened PNN density seems to per-
sist into adulthood in DUP mice, in both PFC and 
TRN. Our data revealed elevated Ncan and Sema3a 
expression in adult DUP mice. Evidence suggests that 
TAOK2 regulates SEMA3A signaling to JNK,16 which 
may explain the Sema3a increase. The Ncan increase 
may indicate this to be a key CSPG, over-produced in 
Notably, we found that DUP and WT neurons respond differently to exogenous BDNF application in culture; JNK and ERK activity 
are not upregulated and there is no apparent BDNF-induced acceleration to PNN development in DUPs. We suggest that this abnormal 
response to BDNF represents a developmental pathology in the 16p11.2 DUP syndrome. We note the importance of the MAPKs 
signaling pathways in the immune and stress responses. The dysregulation of the TAOK-JNK and ERK pathways in DUP neurons may 
lead to an altered response to environmental factors throughout development, with potential consequences to developmental trajectory. 
(d) Diagram of our suggested roles of MAPK pathway signaling in GABAergic and PNN development. Our data indicate a role for both 
the TAOK-JNK and ERK signaling pathways in the regulation of PNN maturation and GABAergic development. However, we found 
the most dramatic changes to PNN gene expression after modulating JNK, which suggest a specific importance of the JNK family in 
the regulation of key PNN components. To our knowledge, these results are the first to highlight the link between MAPK signaling and 
PNN regulation.
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DUPs, due to Taok2 overexpression (and resultant ex-
cess JNK activity). Interestingly, NCAN maps onto a 
GWAS-identified SZ locus, and nonsynonymous de 
novo NCAN mutations are enriched in SZ patients.88 
Together, these findings implicate disrupted Ncan ex-
pression and function in SZ pathology, which may ex-
tend beyond carriers of  the 16p11.2 DUP and affect a 
wider subset of  SZ patients.
Curiously, in the TRN, both WFA and PVB inten-
sity appear to be slightly elevated in comparison to WT. 
These data indicate a complex relationship between PNN 
density and PVB expression and may suggest a diver-
gence of the mechanisms controlling GABAergic inter-
neuron development and regulation across various brain 
regions.89–91
TAOK2-JNK Signaling as a Key Regulatory Pathway 
in Maturation of GABAergic Interneurons and PNNs
Until now it has been unclear how SZ genetic risk factors 
are connected to the characteristic impairments in PFC 
PVB cells. In WT neurons, TAOK inhibition increased the 
Pvalb expression. This is pertinent considering the PVB 
reduction in adult DUP PFC (Taok2 overexpression). It 
suggests a mediatory role for Taok2 in Pvalb expression. 
We did not find the same increase in Pvalb expression 
when ERK was inhibited.
Importantly, while ERK signaling affects some aspects 
of the GABAergic phenotype (eg, Sst expression), ERK 
inhibition did not dramatically affect PNN gene expres-
sion. TAOK inhibition modulated the expression of key 
PNN components, Sema3a, Acan, and Has1, and al-
tered Pvalb and Sst expression. However, JNK inhibi-
tion produced the most dramatic effect on PNN-related 
genes, downregulating all CSPGs and Sema3a, while 
upregulating Has1-3 expression. This suggests that, 
while other MAPKs may be involved to some extent, 
the TAOK2-JNK signaling cascade is a key regulatory 
pathway in GABAergic interneuron and PNN develop-
ment. In fact, given the magnitude of the effects of JNK 
inhibition on CSPGs, we suggest a major role for JNK 
signaling specifically in PNN regulation. An outline of 
our suggested role for MAPK pathways (TAOK-JNK 
and MEK-ERK) in the developmental control of cor-
tical GABAergic interneurons and PNNs is summarized 
in figures 5c and 5d.
Accumulating evidence suggests that dysfunctional 
JNK activity may be a substantial contributor to SZ risk. 
It is clear that cortical interneuron dysfunction accounts 
for some of the pathology and symptomology observed 
in SZ. Understanding the regulators of the development 
of these interneurons is clearly important. These data, 
implicating TAOK2-JNK signaling directly in adverse de-
velopment of PFC GABAergic interneurons and PNNs 
in SZ, highlight a promising novel therapeutic strategy 
for exploration.
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